Duffy antigen/chemokine receptor (DARC) has alternative name : Atypical Chemokine Receptor 1(ACKR1), The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Diseases associated with ACKR1 include Malaria and Plasmodium Vivax Malaria. Among its related pathways are Signaling by GPCR and Peptide ligand-binding receptors. GO annotations related to this gene include G-protein coupled receptor activity and transmembrane signaling receptor activity.
Bovine Duffy antigen/chemokine receptor (DARC) ELISA Kit employs a two-site sandwich ELISA to quantitate DARC in samples. An antibody specific for DARC has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyDARC present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for DARC is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of DARC bound in the initial step. The color development is stopped and the intensity of the color is measured.
Bovine Duffy antigen/chemokine receptor (DARC) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
bio-equip.cn
Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.